Outlook Therapeutics, Inc.
OTLK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649989
In the last 90 days, Outlook Therapeutics, Inc. insiders filed 4 open-market purchases and 0 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $32.2M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Outlook Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 65 | 2 | 67 | +4 |
| Shares | 8.50M | 704.5K | 8.38M | +591.9K (+7.6%) |
| Value | $62.7M | $5.20M | $44.8M | −$12.7M (−22.1%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Outlook Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,044,988 | $5.58M | 0.00% |
| Federated Hermes, Inc. | 91,419 | $488.2K | 0.00% |
| XTX Topco Ltd | 37,328 | $199.3K | 0.01% |
| Goldman Sachs Group Inc | 35,574 | $190.0K | 0.00% |
| Corton Capital Inc. | 31,162 | $166.4K | 0.08% |
| ExodusPoint Capital Management, LP | 11,235 | $60.0K | 0.00% |
| Christensen, King & Associates Investment Services, Inc. | 10,276 | $54.9K | 0.03% |
| The PNC Financial Services Group, Inc. | 10,000 | $53.4K | 0.00% |
| Russell Investments Group, Ltd. | 49 | $262 | 0.00% |
| Sterling Capital Management LLC | 15 | $80 | 0.00% |
| National Bank of Canada | 1 | $5 | 0.00% |
Sold out (7)
Institutions that held Outlook Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Velan Capital Investment Management LP | 247,084 | $1.82M |
| Walleye Capital LLC | 41,426 | $305.7K |
| UBS Oconnor LLC | 36,000 | $265.7K |
| Squarepoint Ops LLC | 31,388 | $231.6K |
| Susquehanna International Group, LLP | 15,678 | $115.7K |
| AQR Capital Management LLC | 10,164 | $75.0K |
| Simplex Trading, LLC | 410 | $3.00K |
Not filed for Q3 2024 yet (2)
Institutions that held Outlook Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 663,496 | $4.90M |
| Susquehanna Fundamental Investments, LLC | 41,020 | $302.7K |